House report: Top drugmakers spend more on investor perks than R&D By Tom Howell Jr. - The Washington Times Shares
Amid AstraZeneca setback, Germany banks on homegrown vaccine By FRANK JORDANS and DAVID McHUGH - Associated Press Shares
Novartis wins approval from FDA to start hydroxychloroquine clinical trial By David Sherfinski - The Washington Times Shares
Novartis to buy The Medicines Company for $9.7 billion By The Associated Press - Associated Press Shares
Drug giant Novartis says it paid Michael Cohen, Trump’s lawyer, $1 million for little work By Dave Boyer - The Washington Times Shares
Greek parliament to probe 10 politicians over pharma scandal By NICHOLAS PAPHITIS and ELENA BECATOROS - Associated Press Shares
